You are here

PNH

Akari CEO resigns amidst dodgy data claims

Akari CEO resigns amidst dodgy data claims

BioPharma Dive

Akari Therapeutics

clinical trials

Flag link:

The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug

The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug

BioPharma Dive

Flag link:

Alnylam Going After World's Most Expensive Drug in New Trials

Alnylam Going After World's Most Expensive Drug in New Trials

Bloomberg

Flag link:

The Cure for Alexion

The Cure for Alexion

TheStreet.com

Flag link:

Soliris Continues to Drive Growth as Alexion Adds to Its Pipeline

Soliris Continues to Drive Growth as Alexion Adds to Its Pipeline

Morningstar

Flag link:

Alexion Hoping Its Soliris Is That Rare Wonder Drug

Alexion Hoping Its Soliris Is That Rare Wonder Drug

Investors.com

Flag link:

Alexion: One-Trick Pony, But It's a Pretty Good Trick

Alexion: One-Trick Pony, But It's a Pretty Good Trick

Seeking Alpha

Flag link:

Alexion Accelerates Plans to Launch Soliris® (Eculizumab) in Japan

Alexion Accelerates Plans to Launch Soliris® (Eculizumab) in Japan

Yahoo

Flag link: